Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) shares were up 0.8% on Friday . The stock traded as high as $2.42 and last traded at $2.40. Approximately 230,134 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 486,688 shares. The stock had previously closed at $2.38.
Eliem Therapeutics Trading Up 0.8%
The firm has a fifty day moving average of $1.82 and a two-hundred day moving average of $1.46. The company has a market cap of $71.40 million, a PE ratio of -4.53 and a beta of -0.39.
About Eliem Therapeutics
Eliem Therapeutics, Inc, a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Featured Articles
- Five stocks we like better than Eliem Therapeutics
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- How to Buy Gold Stock and Invest in Gold
- Congress: The Biggest Trades Impacting Markets Today
- Business Services Stocks Investing
- 3 Companies Boosting Buybacks While Others Pull Back
Receive News & Ratings for Eliem Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eliem Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
